For the Inventor, By the Inventor

Enter assignee name

Miami, FL, United States of America

Key Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 54

CIPO Patents = 1

Forward Citations = 2,998

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Alec D Keith (22 out of 28 patents)

Wallace Snipes (15 out of 16 patents)

Charles H Hsiao (7 out of 9 patents)

4. Nicholas S Bodor (6 out of 86 patents)

5. Ronald R Tuttle (6 out of 7 patents)

6. Thorsteinn Loftsson (4 out of 28 patents)

7. Marvin A Sackner (3 out of 38 patents)

8. Allyn L Golub (3 out of 3 patents)

9. Steven Sablotsky (2 out of 17 patents)

10. Peter C Meltzer (1 out of 30 patents)

11. John M Questel (1 out of 6 patents)

12. James A Thompson (1 out of 2 patents)

13. Herman L Watson (1 out of 14 patents)

14. Arthur M Harris (1 out of 6 patents)

15. Julius Diamond (1 out of 76 patents)

Core Competencies:

Transdermal Dosage Layer

Iontophoretic Drug Delivery

Controlled Release

Percutaneous Penetration Enhancer

Polymeric Diffusion Matrix

Sustained Release

Drug Delivery Method

Intrapulmonary Delivery

Bronchospastic Treatment

Anti-Spilling Capsule

Skin Matrix

Hemorrhoidal Device

54 patents: Sort by Forward Citations

1. 5186938 - Adhesive transdermal dosage layer (1993-02-16),

2. 4983396 - Percutaneous penetration enhancer of oleic acid and (1991-01-08),

3. 4885174 - Percutaneous penetration enhancer of oleic acid and (1989-12-05),

4. 4863743 - Controlled release potassium chloride (1989-09-05),

5. 4859707 - Sulfur-substituted phenylacetamides (1989-08-22),

6. 4764381 - Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, (1988-08-16),

7. 4722726 - Method and apparatus for iontophoretic drug delivery (1988-02-02),

8. 4708867 - Minipellets (1987-11-24),

9. 4689213 - Method and composition for treating bronchospastic airway diseases (1987-08-25),

10. 4679555 - Method and apparatus for intrapulmonary delivery of heparin (1987-07-14),

11. 4639455 - Means of aiding in the prevention of sudden infant death syndrome (1987-01-27),

12. 4634587 - Sustained release quinidine dosage form (1987-01-06),

13. 4594356 - Method for inducing mydriasis in animals (1986-06-10),

14. 4587118 - Dry sustained release theophylline oral formulation (1986-05-06),

15. 4585452 - Transdermal systemic dosage forms (1986-04-29),

Company Overview

Key Pharmaceuticals, Inc., based in Miami, FL, specializes in the development of advanced transdermal drug delivery systems. The company focuses on innovative technologies such as iontophoretic drug delivery, controlled release mechanisms, and polymeric diffusion matrices. Key Pharmaceuticals aims to enhance therapeutic efficacy through sustained release and improved percutaneous penetration methods. Their research is pivotal in creating effective drug delivery solutions that cater to various medical needs, positioning them as a leader in the pharmaceutical technology landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

54 Patents

#14 in Miami, FL

#153 in Florida

#6,579 in US

#13,162 in the World

Miami, FL, United States of America

Key Pharmaceuticals, Inc.

Forward Citations = 2,998

23 inventors:

Alec D Keith (22 out of 28 patents)

Wallace Snipes (15 out of 16 patents)

Charles H Hsiao (7 out of 9 patents)

4. Nicholas S Bodor (6 out of 86 patents)

5. Ronald R Tuttle (6 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Key Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/key-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…